(603566)"Pulike Biological Engineering, Inc."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 603566 · · 3 pages · Chinese
Pulike Biological Engineering, Inc. on 6ix
Story so far
- (603566)"Pulike Biological Engineering, Inc."Announcement on Obtaining the Approval for the Clinical Trial of Veterinary Biological Products
- Announcement on Change of Sponsor Representative for Continuous Supervision and Guidance
- Announcement on Obtaining New Veterinary Drug Registration Certificate by Subsidiary
Earlier from Pulike Biological Engineering
- (603566)"Pulike Biological Engineering, Inc."Announcement on Obtaining the Approval for the Clinical Trial of Veterinary Biological Products
- Announcement on Change of Sponsor Representative for Continuous Supervision and Guidance
- Announcement on Obtaining New Veterinary Drug Registration Certificate by Subsidiary
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
Later from Pulike Biological Engineering
- (603566)"Pulike Biological Engineering, Inc."Announcement on Obtaining New Veterinary Drug Registration Certificate
- (603566)"Pulike Biological Engineering, Inc."Announcement on Obtaining New Veterinary Drug Registration Certificate by Subsidiary
Follow Pulike Biological Engineering into a list and get an email when it puts out news.
Follow Pulike Biological Engineering